Label: BENZEFOAM ULTRA- benzoyl peroxide aerosol

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated February 6, 2020

If you are a consumer or patient please visit this version.

  • Active ingredient

    Benzoyl Peroxide (9.8%)

  • Purpose

    Acne Treatment

  • Use

    For the treatment of acne.

  • Warnings

    For external use only

  • Do not use if you

    ■ have very sensitive skin

    ■ are sensitive to benzoyl peroxide

  • When using this product

    skin irritation and dryness are more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
    avoid unnecessary sun exposure and use a sunscreen.
    avoid contact with the eyes, lips, and mouth.
    avoid contact with hair and dyed fabrics, which may be bleached by this product.
    skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.
    do not puncture or incinerate container. Contents under pressure.
    do not expose to temperatures above 120°F (49°C).
  • Stop use and ask a doctor if

    ■ irritation becomes severe

  • Keep Out of Reach of Children

    If swallowed get medical help or contact a Poison Control Center right away.

  • Directions

    clean the skin thoroughly before applying this product
    cover the entire affected area with a thin layer one to three times daily
    rinse off after 2 minutes
    because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
    if bothersome dryness or peeling occurs, reduce application to once a day or every other day
    if going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor
    to be used as a short contact application
  • Other Information

    ■ store at room temperature 15°-25°C (59°-77°F). Protect from freezing. Store upright.

  • Inactive Ingredients

    BHT, C12-15 alkyl benzoate, cetearyl alcohol, citric acid, dimethicone, disodium EDTA, emulsifying wax, glycerin, hydrofluorocarbon 134a, methylparaben, propylene glycol, propylparaben, purified water,

    sodium citrate, steareth-10

  • Questions/comments?

    Call: 1-800-321-4576

  • Package/Label Principal Display Panel - Carton

    NDC: 0187-0194-10

    BenzEFoam Ultra

    benzoyl peroxide 9.8%

    Acne Treatment
    Short Contact Foam

    For Topical Use Only
    Do Not Use in Eyes

    Will not dispense entire contents.
    Container is overfilled to guarantee
    dispensing a minimum of 100 grams.

    Back Applicator Included

    Ortho Dermatologics

    Net Wt 3.5 OZ (100 g)

    carton.jpg
  • INGREDIENTS AND APPEARANCE
    BENZEFOAM ULTRA 
    benzoyl peroxide aerosol
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0187-0201
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZOYL PEROXIDE (UNII: W9WZN9A0GM) (BENZOYL PEROXIDE - UNII:W9WZN9A0GM) BENZOYL PEROXIDE9.8 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
    ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
    CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    NORFLURANE (UNII: DH9E53K1Y8)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    WATER (UNII: 059QF0KO0R)  
    SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)  
    STEARETH-10 (UNII: FD0913P475)  
    POLYSORBATE 60 (UNII: CAL22UVI4M)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0187-0201-101 in 1 CARTON02/06/2020
    1100 g in 1 CAN; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart333D02/06/2020
    Labeler - Bausch Health US, LLC (831922468)
    Establishment
    NameAddressID/FEIBusiness Operations
    Denison Pharmaceuticals001207208MANUFACTURE(0187-0201)